title: [Rosuvastatin-induced erythema multiforme].
authors.forename: Rosmeri
authors.initials: R
authors.lastname: Rivera Irigoín
authors.forename: Joana
authors.initials: J
authors.lastname: Nicolau Ramis
authors.forename: Fernando
authors.initials: F
authors.lastname: Terrasa Sagrista
authors.forename: Lluís
authors.initials: L
authors.lastname: Masmiquel Comas
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018771:Arthralgia / Q000139:chemically induced; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D057915:Drug Substitution; D004630:Emergencies; D004892:Erythema Multiforme / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005464:Fluorobenzenes / Q000009:adverse effects*; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D000893:Anti-Inflammatory Agents; D005464:Fluorobenzenes; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D015248:Gemfibrozil; D011241:Prednisone